Design, synthesis, and biological evaluation of 2-(phenoxyaryl)-3-urea derivatives as novel P2Y1 receptor antagonists

被引：13

作者：

Peng, Jingjing ^{[1
,2
]}

Zhao, Lifen ^{[1
]}

Wang, Lanlan ^{[3
]}

Chen, Hui ^{[1
,2
]}

Qiu, Yunguang ^{[1
,2
]}

Wang, Jiang ^{[1
,2
]}

Yang, Huaiyu ^{[4
]}

Liu, Jun ^{[3
]}

Liu, Hong ^{[1
,2
]}

机构：

[1] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China

[2] Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China

[3] China Pharmaceut Univ, Jiangsu Key Lab Drug Screening, Nanjing 210009, Jiangsu, Peoples R China

[4] East China Normal Univ, Sch Life Sci, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2018年 / 158卷

基金：

中国国家自然科学基金;

关键词：

P2Y(1) receptor antagonist; 2-(phenoxyaryl)-3-urea derivatives; Anti-Platelet; PLATELET-AGGREGATION; ANTIPLATELET AGENTS; HIGH-AFFINITY; DIARYL UREAS; THROMBOSIS; DISCOVERY; POTENT; MICE; PHARMACOKINETICS; CLOPIDOGREL;

D O I：

10.1016/j.ejmech.2018.09.014

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A novel series of 2-(phenoxyaryl)-3-urea derivatives were designed, synthesized, and biologically evaluated for their anti-thrombotic activity. Most of compounds exhibited good inhibition against P2Y(1) receptor. Among them, three compounds 11, 12, and 13 demonstrated good P2Y(1) receptor antagonistic potency in vitro (IC50 = 0.62 mu M, 0.82 mu M, and 0.21 mu M, respectively). In antiplatelet aggregation study, four compounds 2, 3, 9, and 13 showed good antiplatelet activity. The possible binding modes of compounds with P2Y(1) receptor were also explored by molecular docking simulation. The docking studies demonstrated that compound 13 interacted well with Phe119 through hydrophobic interaction and modestly improved the P2Y(1) receptor antagonistic activity, making it justifiable for further investigation. (C) 2018 Published by Elsevier Masson SAS.

引用

页码：302 / 310

页数：9

共 50 条

[31] Calmodulin interacts with the platelet ADP receptor P2Y1 [J].

Arthur, Jane F. ;

Shen, Yang ;

Mu, Fi-Tjen ;

Leon, Catherine ;

Gachet, Christian ;

Berndt, Michael C. ;

Andrews, Robert K. .

BIOCHEMICAL JOURNAL, 2006, 398 (339-343) :339-343

[32] Study of aggregation of platelets lacking the P2Y1 receptor [J].

Fabre, JE ;

King, BF ;

Koller, BH .

DRUG DEVELOPMENT RESEARCH, 2001, 52 (1-2) :150-155

[33] Synthesis, structure-property relationships and pharmacokinetic evaluation of ethyl 6-aminonicotinate sulfonylureas as antagonists of the P2Y12 receptor [J].

Bach, Peter ;

Bostrom, Jonas ;

Brickmann, Kay ;

van Giezen, J. J. J. ;

Groneberg, Robert D. ;

Harvey, Darren M. ;

O'Sullivan, Michael ;

Zetterberg, Fredrik .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 65 :360-375

[34] Design, synthesis, and biological evaluation of 1-ethyl-3-(thiazol-2-yl)urea derivatives as Escherichia coli DNA gyrase inhibitors [J].

Tomasic, Tihomir ;

Barancokova, Michaela ;

Zidar, Nace ;

Ilas, Janez ;

Tammela, Paivi ;

Kikelj, Danijel .

ARCHIV DER PHARMAZIE, 2018, 351 (01)

[35] Design, Synthesis and Biological Evaluation of Novel 1,2,5-Oxadiazol-3-Carboximidamide Derivatives as Indoleamine 2, 3-Dioxygenase 1 (IDO1) Inhibitors [J].

Xia, Zhifeng ;

Nan, Yanyang ;

Liu, Chang ;

Lin, Guangyu ;

Gu, Kedan ;

Chen, Cheng ;

Zhao, Weili ;

Ju, Dianwen ;

Dong, Xiaochun .

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2020, 20 (13) :1592-1603

[36] Synthesis and biological evaluation of 3-(2-aminoethyl) uracil derivatives as gonadotropin-releasing hormone (GnRH) receptor antagonists [J].

Kim, Seon-Mi ;

Lee, Minhee ;

Lee, So Young ;

Lee, Soo-Min ;

Kim, Eun Jeong ;

Kim, Jae Sun ;

Ann, Jihyae ;

Lee, Jiyoun ;

Lee, Jeewoo .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 145 :413-424

[37] Design, synthesis and biological evaluation of mogrol derivatives as a novel class of AMPKα2β1γ1 activators [J].

Wang, Junwei ;

Liu, Junhua ;

Xie, Zhifu ;

Li, Jia ;

Li, Jingya ;

Hu, Lihong .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (02)

[38] Design, synthesis, and biological evaluation of novel diarylalkyl amides as TRPV1 antagonists [J].

Li, Fu-Nan ;

Kim, Nam-Jung ;

Paek, Seung-Mann ;

Kwon, Do-Yeon ;

Min, Kyung Hoon ;

Jeong, Yeon-Su ;

Kim, Sun-Young ;

Park, Young-Ho ;

Kim, Hee-Doo ;

Park, Hyeung-Geun ;

Suh, Young-Ger .

BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (10) :3557-3567

[39] Simultaneous Platelet P2Y12 and P2Y1 ADP Receptor Blockade Are Two Better Than One? [J].

Vaduganathan, Muthiah ;

Bhatt, Deepak L. .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (03) :427-428

[40] Design, synthesis and biological evaluation of quinoline amide derivatives as novel VEGFR-2 inhibitors [J].

Yang, Ying ;

Shi, Lei ;

Zhou, Yang ;

Li, Huan-Qiu ;

Zhu, Zhen-Wei ;

Zhu, Hai-Liang .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (22) :6653-6656

← 1 2 3 4 5 →